tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JANX Stock Latest News

Janux Therapeutics initiated with a Buy at Guggenheim
The FlyJanux Therapeutics initiated with a Buy at Guggenheim
3d ago
JANX
Janux Therapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
Janux Therapeutics initiated with a Buy at Guggenheim
3d ago
JANX
Piper starts Janux Therapeutics with an Overweight on ‘best-in-class’ potential
PremiumThe Fly
Piper starts Janux Therapeutics with an Overweight on ‘best-in-class’ potential
19d ago
JANX
Janux Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Janux Therapeutics initiated with an Overweight at Piper Sandler
19d ago
JANX
Buy Rating for Janux Therapeutics Driven by Promising Tumor-Conditional Masking Platform and Strategic Collaborations
PremiumRatings
Buy Rating for Janux Therapeutics Driven by Promising Tumor-Conditional Masking Platform and Strategic Collaborations
23d ago
JANX
Promising Future for Janux Therapeutics: Buy Rating Backed by Strong Clinical Profile and Strategic Trials
PremiumRatingsPromising Future for Janux Therapeutics: Buy Rating Backed by Strong Clinical Profile and Strategic Trials
25d ago
JANX
Promising Developments and Strategic Expansion at Janux Therapeutics: Analyst Sets $70 Price Target
Premium
Ratings
Promising Developments and Strategic Expansion at Janux Therapeutics: Analyst Sets $70 Price Target
27d ago
JANX
Buy Rating for Janux Therapeutics Driven by Promising Pipeline and Strong Financial Position
Premium
Ratings
Buy Rating for Janux Therapeutics Driven by Promising Pipeline and Strong Financial Position
29d ago
JANX
Janux Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Janux Therapeutics Reports Q2 2025 Financial Results
30d ago
JANX
Optimistic Outlook for Janux Therapeutics: Strong Cash Position and Promising ‘007 Program Drive Buy Rating
PremiumRatings
Optimistic Outlook for Janux Therapeutics: Strong Cash Position and Promising ‘007 Program Drive Buy Rating
1M ago
JANX
Optimistic Buy Rating for Janux Therapeutics Inc. Driven by Promising R&D, Strong Cash Position, and Strategic Expansion
PremiumRatings
Optimistic Buy Rating for Janux Therapeutics Inc. Driven by Promising R&D, Strong Cash Position, and Strategic Expansion
1M ago
JANX
Promising Pipeline and Financial Stability Support Buy Rating for Janux Therapeutics Inc
PremiumRatings
Promising Pipeline and Financial Stability Support Buy Rating for Janux Therapeutics Inc
1M ago
JANX
Janux Therapeutics reports Q2 EPS (55c), consensus (47c)
PremiumThe FlyJanux Therapeutics reports Q2 EPS (55c), consensus (47c)
1M ago
JANX
Janux Therapeutics reaches clinical milestone in Merck TRACTr collaboration
Premium
The Fly
Janux Therapeutics reaches clinical milestone in Merck TRACTr collaboration
1M ago
MRK
JANX
Janux Therapeutics: Strategic Innovations and Robust Pipeline Drive Buy Rating
Premium
Ratings
Janux Therapeutics: Strategic Innovations and Robust Pipeline Drive Buy Rating
1M ago
JANX
Optimistic Buy Rating for Janux Therapeutics Driven by Strategic Pipeline and Diversification
PremiumRatings
Optimistic Buy Rating for Janux Therapeutics Driven by Strategic Pipeline and Diversification
1M ago
JANX
Janux Therapeutics Inc: Strategic Advancements and Strong Positioning in Oncology Drive Buy Rating
PremiumRatings
Janux Therapeutics Inc: Strategic Advancements and Strong Positioning in Oncology Drive Buy Rating
1M ago
JANX
Janux Therapeutics’ Strategic Expansion and Promising Pipeline Drive Buy Rating
PremiumRatings
Janux Therapeutics’ Strategic Expansion and Promising Pipeline Drive Buy Rating
1M ago
JANX
Janux Therapeutics Faces Trade Policy Challenges: Impact on Operations and Growth
PremiumCompany Announcements
Janux Therapeutics Faces Trade Policy Challenges: Impact on Operations and Growth
1M ago
JANX
Innovative Preclinical Programs and Strategic Tumor Activation Drive Buy Rating for Janux Therapeutics
PremiumRatingsInnovative Preclinical Programs and Strategic Tumor Activation Drive Buy Rating for Janux Therapeutics
1M ago
JANX
Strategic Initiatives and Long-Term Potential Drive Buy Rating for Janux Therapeutics Inc.
Premium
Ratings
Strategic Initiatives and Long-Term Potential Drive Buy Rating for Janux Therapeutics Inc.
2M ago
JANX
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
Premium
The Fly
CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
2M ago
AMC
BYD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >